Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;41(3):816-820.
doi: 10.12669/pjms.41.3.9717.

Aberrant immunophenotypic expressions in childhood acute leukemias: A tertiary care hospital experience

Affiliations

Aberrant immunophenotypic expressions in childhood acute leukemias: A tertiary care hospital experience

Nazish Saqlain et al. Pak J Med Sci. 2025 Mar.

Abstract

Background & objective: Pediatric acute leukemias can present with aberrant immunophenotypes characterized by a different pattern of antigen expression on malignant cells, unlike the process of usual hematopoietic maturation. The objective of this study was to determine the aberrant immunophenotype expressions in newly diagnosed pediatric acute lymphoblastic and acute myeloid leukemias.

Methods: This cross-sectional study was carried out at University of Child Health Sciences, The Children's Hospital, Lahore, from October 2022 to December 2022 after IRB approval. After taking informed consent from parents/guardians, 290 children diagnosed with acute leukemia were included in the study. Peripheral blood or bone marrow samples in EDTA vial were used for flowcytometric analysis by using BD FACS Canto II flow-cytometer. The data was collected on a pre-designed proforma and analyzed by using IBM-SPSS V-23.

Result: Among 290 cases, Acute Lymphoblastic Leukemia (ALL) constituted 221(76.2%) cases and 69(23.7%) were Acute Myeloid Leukemia (AML). Out of the total, the aberrant antigens were present in 32(11%) patients with 40 total events (18.1% immunophenotype aberrancy rate). The most common aberrant antigens were reported in B-ALL and the most common aberrant expression was of CD13 (62.5%). In AML, the most common aberrant antigen seen was CD19 (55.6%) and in T-ALL the most common were CD117 and HLA-DR (26.6%).

Conclusion: The most aberrant immunophenotypic markers were seen mostly in B-ALL pediatric cases followed by AML and T-ALL. Such abnormal expressions should be kept in mind while diagnosing the children with acute leukemia as they may affect the prognosis.

Keywords: Aberrant markers; Acute leukemia; Children; Immunophenotypic expression; Minimal Residual Disease.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Case of B-ALL with aberrant expression of CD13.
Fig.2
Fig.2
Acute myeloid leukemia with aberrant expression of CD2.

Similar articles

References

    1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Switzerland: World Health Organization Press; 2017. pp. 168–178.
    1. Vora A. Childhood acute lymphoblastic leukaemia. In: Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB, editors. Postgrad Haematol. 7th edition. Vol. 22. UK: Wiley Blackwell Publishing; 2016. pp. 384–398.
    1. Morilla R, Morilla AM, Nadal-Melsió E. Immunophenotyping by flow cytometry. In: Bain BJ, Bates I, Laffan MA, editors. Dacie Lewis Pract Haematol. 12th edition. Vol. 16. Philadelphia: Elsevier Limited; 2017. pp. 330–349.
    1. Mohamed MA, Shafik EA, Ahmed AO, Sayed DM. Expression of aberrant markers in acute leukemia at south Egypt cancer institute:A retrospective study. SECI Oncol. 2021;9:53–63.
    1. Shahni A, Saud M, Siddiqui S, Mukry SN. Expression of aberrant antigens in hematological malignancies:A single center experience. Pak J Med Sci. 2018;34(2):457–462. doi:10.12669/pjms.342.13996. - PMC - PubMed

LinkOut - more resources